Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.
Graft-versus-host disease is one of the major problems in clinical bone marrow transplantation. Many experiments in animals have shown that it could be greatly reduced if mature T lymphocytes were removed from the donor marrow. Here we describe a new rat monoclonal antibody, CAMPATH 1, which is suit...
Main Authors: | Hale, G, Bright, S, Chumbley, G, Hoang, T, Metcalf, D, Munro, A, Waldmann, H |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1983
|
Similar Items
-
THE USE OF MONOCLONAL ANTILYMPHOCYTE ANTIBODIES IN CLINICAL IMMUNOSUPPRESSION
by: Friend, P, et al.
Published: (1985) -
Prophylactic use of an antilymphocyte monoclonal antibody following renal transplantation: a randomized controlled trial.
by: Friend, P, et al.
Published: (1987) -
Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
by: Thierfelder, S, et al.
Published: (1985) -
CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
by: Hale, G, et al.
Published: (1994) -
Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody.
by: Friend, P, et al.
Published: (1995)